Skip to main content
GutCited

Butyrate (Sodium/Calcium Butyrate) pour Ulcerative Colitis (UC)

C

Recent 90-day RCT (140 IBD participants) showed oral butyrate improved Crohn's symptoms and QoL. Earlier studies on butyrate enemas showed benefit in distal UC.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbutyrate\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Recent 90-day RCT (140 IBD participants) showed oral butyrate improved Crohn's symptoms and QoL. Earlier studies on butyrate enemas showed benefit in distal UC.

Key Study Findings

Randomized Controlled Trial n=140 Double-blind
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study …
Dose: None vs: placebo plus conventional therapy Outcome: clinical disease activity and fecal calprotectin Effet: None p=0.013

Population: IBD patients (60 Crohn's disease, 80 ulcerative colitis)

basic science
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.
Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo Effet: None < 0.05
In Vitro
Sea buckthorn berries alleviate ulcerative colitis via regulating gut Faecalibaculum rodentium-mediated butyrate biosynthesis.
Dose: None vs: DSS-induced UC mice model Outcome: UC symptom alleviation via gut microbiota Effet: None p<0.05

Population: DSS-induced UC murine model

In Vitro
Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4+ T cell …
Dose: None vs: UC animal and clinical samples Outcome: Intestinal inflammation via CD4+ T cell regulation Effet: None None

Population: UC murine model + UC patient samples

Randomized Controlled Trial n=36 12 weeks Double-blind
Effects of Short Chain Fatty Acid-Butyrate Supplementation on the Disease Severity, Inflammation, and Psychological Factors …
Dose: 600 mg/kg with main meal vs: Placebo (rice starch) Outcome: Mayo score, ESR, anxiety/depression (HADS) Effet: Mayo score -2.33 vs +0.22 p<0.001 (Mayo, dep, GHQ)

Population: Active ulcerative colitis patients

In Vitro
Sodium butyrate regulates macrophage polarization by TGR5/β-arrestin2 in vitro.
Dose: None vs: LPS-stimulated RAW264.7 cells Outcome: Macrophage polarization (M1 to M2 shift) Effet: None None

Population: RAW264.7 macrophage cell line

Key Statistics

3

Études

390

Participants

Positive

C

Note

Referenced Papers

Molecular medicine (Cambridge, … 2025 8 citations
Langenbeck's archives of … 2025 3 citations
Nutrients 2023 9 citations
Current pharmaceutical design 2018 108 citations
Comprehensive Physiology 2017 245 citations
Journal of AOAC … 2004
Current opinion in … 2000 28 citations
Diseases of the … 1998 26 citations
Digestive diseases and … 1997 254 citations
Bailliere's clinical gastroenterology 1997 26 citations
Diseases of the … 1995 31 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
150-600 mg/day sodium or calcium butyrate
ibdsupport:
300-600 mg three times daily (900-1,800 mg/day)
butyrateenema:
100 mM butyrate enema for distal UC (clinical setting only)

Limite supérieure : No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive 140
Lactobacillus reuteri E9 (dose not specified) -- Positive --
None -- Positive --
None -- Positive --
600 mg/kg with main meal 12 weeks Positive 36
None -- Positive --
5 mg/mL -- Positive --
None -- Positive --

Moment optimal de prise : With meals; enteric-coated formulations recommended to reach the colon

Safety & Side Effects

Effets indésirables signalés

  • Unpleasant taste/odor (butyric acid has a strong rancid butter smell)
  • Mild GI discomfort (nausea, bloating)
  • Belching with butyric acid odor
  • Enteric-coated formulations reduce taste issues

Interactions connues

  • 5-ASA medications (mesalamine) — additive anti-inflammatory effect (potentially beneficial in IBD)
  • No significant adverse drug interactions known

Apport maximal tolérable : No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Butyrate (Sodium/Calcium Butyrate) help with Ulcerative Colitis (UC)?
Based on 3 studies with 390 participants, there is limited but promising evidence that Butyrate (Sodium/Calcium Butyrate) may support Ulcerative Colitis (UC) management. Our evidence grade is C (Some Evidence).
How much Butyrate (Sodium/Calcium Butyrate) should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 150-600 mg/day sodium or calcium butyrate. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Butyrate (Sodium/Calcium Butyrate)?
Reported side effects may include Unpleasant taste/odor (butyric acid has a strong rancid butter smell), Mild GI discomfort (nausea, bloating), Belching with butyric acid odor, Enteric-coated formulations reduce taste issues. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Butyrate (Sodium/Calcium Butyrate) and Ulcerative Colitis (UC)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 390 total participants. The overall direction of effect is positive.

Related Evidence

Butyrate (Sodium/Calcium Butyrate) pour d'autres pathologies

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.